project x bpc 157 BPC-157 and TB-500: Injury Healing Peptides | Jonathan L. Glashow posted on the topic BPC-157 - Rocky Mountain Peptides

These washout periods, which are highlighted in the Summary of Major Modifications and Explanatory Note, are based on the use of these medications according to the maximum manufacturers licensed doses

Dosage and frequency of injections varies depending on the patient's condition

An instructive example might also be the counteracted effect of the cuprizone, a neurotoxin commonly used to produce multiple-sclerosis-like lesions in rats, attenuated brain lesions, and recovered muscle functions [80]

Common causes include liver disease (which releases stored B12), kidney disease (reducing B12 clearance), haematological malignancies, solid tumours, and excessive supplementation